How Trump’s selection of RFK Jr. as HHS secretary could impact the pharma sector

November 15, 2024
How Trump’s selection of RFK Jr. as HHS secretary could impact the pharma sectorHow Trump’s selection of RFK Jr. as HHS secretary could impact the pharma sector
Share This

Jared Holz, healthcare sector strategist at Mizuho Securities America, and CNBC’s Angelica Peebles join ‘Power Lunch’ discuss pharma stocks’ reaction to Robert F. Kennedy Jr.’s appointment to lead the Department of Health and Human Services, what the incoming administration could mean for regulation in the sector, and more.

Latest Mizuho News

Mizuho’s Jared Holz on Moderna’s leg up on new cancer shot data

Mizuho’s Jared Holz on Moderna’s leg up on new cancer shot data

August 19, 2026
Nvidia holders to focus on AI data, Mizuho's Rakesh says

Nvidia holders to focus on AI data, Mizuho's Rakesh says

August 26, 2026
Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

August 10, 2026

Mizuho news from around the globe

back-to-top-blue